Bone Biologics (BBLG) Earnings Date & Reports

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BBLG is expected to report earnings to fall 58.14% to -18 cents per share on December 02

Bone Biologics BBLG Stock Earnings Reports

Q3'26

Est.

$-0.18

Q2'26

Missed

by $0.04

Q4'25

Beat

by $6.98

Q3'25

Beat

by $7.55

Q2'25

Beat

by $6.51

The last earnings report on September 02 showed earnings per share of -43 cents, missing the estimate of -38 cents. With 2.68K shares outstanding, the current market capitalization sits at 1.52M.

View a ticker or compare two or three

BBLG

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for BBLG